Aurobindo Pharma - 4QFY2013 Result Review - Angel Broking

Aurobindo Pharmaceuticals posted numbers, above expectation on the sales front, while net profit came in mostly in line with expectations. On the sales front, the company posted sales of Rs. 155cr, a growth of 32.5% yoy. The margins came in at 14.3% V/s10.2% in the corresponding period of last year, which lead the company to post a reported net profit of Rs. 108.6cr V/s a net profit of Rs. 108.0cr, respectively.

We maintain our buy with a target of 264.

Source : Equity Bulls

Keywords